Ani pharmaceuticals receives clearance from u.s. federal trade commission for the acquisition of novitium pharma

Baudette, minn.--(business wire)--ani pharmaceuticals, inc. (nasdaq: anip) (ani or the company) today announced that the u.s. federal trade commission (the ftc) has accepted the proposed consent order in connection with ani's definitive agreement to acquire novitium pharma. the divestitures required by the ftc of development rights to one generic drug and assets with respect to another generic drug are immaterial to the company's business. the acceptance by the ftc satisfies all required antitr
ANIP Ratings Summary
ANIP Quant Ranking